Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

LX-9211: development of an AAK1 inhibitor for neuropathic pain

Aug. 30, 2021

Mindset Pharma discloses 5-HT2A receptor agonists

Aug. 30, 2021

Data presented for Sage Therapeutics' SAGE-718 for neurological diseases

Aug. 27, 2021

Landos collaborates with Johns Hopkins to further validate NLRX1 immunometabolic pathway in MS

Aug. 27, 2021

Cannabinoid CB1/CB2 receptor partial agonists patented by Research Triangle Institute

Aug. 27, 2021

Stachydrine-leonurine conjugate SL-06 ameliorates experimental cerebral ischemic stroke

Aug. 25, 2021

Study of MAPT-mutated cerebral organoids reveals mechanisms of glutamatergic cortical neuronal death

Aug. 25, 2021

New dual orexin receptor agonists for the treatment of orexin-deficient disorders such as narcolepsy

Aug. 25, 2021

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

Aug. 23, 2021

AAV9 gene therapy enters clinical development for Canavan disease

Aug. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...